Press release
Angiotensin Receptor Blockers (ARBs) Market Trends, Strategies, Size, Share And Analysis 2024-2033
Angiotensin Receptor Blockers (ARBs) Market
Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $10.28 billion In 2028 At A CAGR Of 4.5%.
The angiotensin receptor blockers (arbs) market size has grown steadily in recent years. It will grow from $8.26 billion in 2023 to $8.62 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to hypertension epidemic, clinical efficacy, cardiovascular disease burden, renal protection, clinical guidelines, arbs as first-line treatment, cost-effectiveness..
The angiotensin receptor blockers (arbs) market size is expected to see steady growth in the next few years. It will grow to $10.28 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to precision medicine approaches, focus on combination therapies, global expansion of market, biomarker-based treatment strategies, government initiatives, increased awareness of hypertension.. Major trends in the forecast period include telemedicine adoption, research and development investments, generic competition and patent expirations, digital health solutions for medication adherence, biosimilar competition..
Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
Angiotensin Receptor Blockers (ARBs) Market Major Segments
The angiotensin receptor blockers (arbs) market covered in this report is segmented -
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Key Driver - Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blockers Market
The increasing incidence of cardiovascular diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Cardiovascular disease (CVD) is any condition affecting the heart or blood vessels. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. Angiotensin receptor blockers lower blood pressure and improve the heart's capacity to pump blood by helping in vein and artery relaxation, which can minimize the risk of cardiovascular disease. For instance, in August 2022, according to the American College of Cardiology, a US-based professional medical organization, the expected rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the angiotensin receptor blockers market.
Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=8943&type=smp
Prominent Trend - Innovative Product Solution In The Angiotensin Receptor Blockers Market
Product innovation is a key trend in gaining popularity in the angiotensin receptor blockers market. Major companies operating in the angiotensin receptor blocker market are focused on developing innovative solutions to strengthen their position in the market. For instance, in February 2021, Novartis AG, a Switzerland-based pharmaceutical company, launched Entresto (sacubitril/valsartan). Entresto (sacubitril/valsartan) has been granted an expanded indication by the United States Food and Drug Administration to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. The clinical benefits are most noticeable in patients with a lower-than-normal left ventricular ejection fraction (LVEF). Entresto is the first and only therapy approved in the United States to treat patients with guideline-defined heart failure, which includes both those with heart failure with reduced ejection fraction (HFrEF) and many with heart failure with preserved ejection fraction (HFpEF).
Angiotensin Receptor Blockers (ARBs) Market Players
Major companies operating in the angiotensin receptor blockers (arbs) market report are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Movianto, Clinical Trial Logistics, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma .
View The Full Report Here - https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report
Largest And Fastest Growing Region In The Market
North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2023. The regions covered in the angiotensin receptor blockers (arbs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Angiotensin Receptor Blockers (ARBs) Market Report Structure
3. Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies
4. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario
5. Angiotensin Receptor Blockers (ARBs) Market Size And Growth
…..
27. Angiotensin Receptor Blockers (ARBs) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiotensin Receptor Blockers (ARBs) Market Trends, Strategies, Size, Share And Analysis 2024-2033 here
News-ID: 3533402 • Views: …
More Releases from The Business research company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for Angiotensin
Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blo …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Angiotensin Receptor Blockers (ARBs) Market Through 2025?
The market size of angiotensin receptor blockers (ARBs) has seen a consistent growth in the past years. The market is projected to expand from $8.51 billion in 2024 to $8.87 billion in 2025, with a compound annual growth rate (CAGR)…
Angiotensin Converting Enzyme (ACE) Inhibitors Market
Angiotensin Converting Enzyme (ACE) inhibitors are a class of pharmaceutical drugs used primarily for the treatment of high blood pressure (hypertension), heart failure, and chronic kidney diseases. These medications help to relax blood vessels, thereby lowering blood pressure and improving heart function. ACE inhibitors block the activity of the enzyme that converts angiotensin I to angiotensin II, a peptide that narrows blood vessels. By inhibiting this conversion, ACE inhibitors enable…
Angiotensin Converting Enzyme (ACE) Inhibitors Market: An Overview
Angiotensin Converting Enzyme (ACE) inhibitors are a class of medications widely used in the treatment of various cardiovascular conditions, primarily high blood pressure (hypertension) and heart failure. These drugs work by blocking the action of the enzyme angiotensin-converting enzyme, which is responsible for producing a substance called angiotensin II. Angiotensin II constricts blood vessels and raises blood pressure. By inhibiting this enzyme, ACE inhibitors help relax blood vessels, lower blood…
Prominent Angiotensin Receptor Blockers (ARBs) Market Trend for 2025: Innovative …
What market dynamics are playing a key role in accelerating the growth of the angiotensin receptor blockers (arbs) market?
The upward trend of cardiovascular diseases is predicted to fuel advancements in the angiotensin receptor blockers market. Often related to the accumulation of fatty components within the arteries (atherosclerosis) and heightened probability of blood clots, cardiovascular disease (CVD) influences the heart or blood vessels. The function of angiotensin receptor blockers is to…
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…
